Additional Content Download
[Interactive] Automation Fundamentals Guide for Compound Management | 13th Compound and Sample Management Summit
Empower your technicians by freeing up their valuable time. Decrease their need to perform laborious, time-consuming tasks by implementing automation into your laboratory operations. Allow your technicians to focus their expertise on advancements in drug discovery. That is the end goal of automation... getting there is another story. We highly recommend you scan this fundamentals review, so you are on the same page as your peers going into the summit.
Compound Management Today: Abbvie's Head of Compound Management Tells All | 13th Compound and Sample Management Summit
Carsten Aprill, Head of Compound Management, Abbvie GmbH and Co KG, speaks to Pharma IQ about how automation has redefined compound management and which technology he thinks has had the best compound management application. Aprill also shares his top tip for a successful compound management strategy.
Next generation compound management– Where do we go from here? In this report, Pharma IQ examines the key challenges in compound management today, requirements for success and plans for investment. In this new report, we present a first look at the results from the Compound & Sample Management 2015 Survey and provide expert insight and analysis from key opinion leaders in the field on:
- Ensuring IP integrity within a collaboration
- Automation and data
- Defining compound management processes
- Leveraging software to create effective compound management processes
- High-throughput screening
Pfizer & Merck on Trends in Compound & Sample Management | 13th Compound and Sample Management Summit
What are the biggest logistical challenges for global sample management? How have automated workflows improved the drug delivery process? What quality control methods are most effective? Cindy Schulz, Manager, Logistics & Data Management, Pfizer and Catherine Quintero, Senior Research Scientist, Merck Boston answer these questions and more about the trends in Compound and Sample Management.
Your scientists have their hands full with projects that require a high level of expertise – is it necessary to have them performing rote tasks like filling tubes? Turns out, not anymore… automation is sweeping the industry, and should rightly be piquing your interest. We’ve put together an advice package to start your exploration of this opportunity in advance of the Summit.
Compound Bank Re-Engineering – Implementing New Technologies to Enable Cutting-Edge Assay Methods | 13th Compound and Sample Management Summit
Past speaker Gregory Wendel, Ph.D., Head, Sample Management and Engineering at Novartis Institute for Biomedical Research, goes into Novartis & NIBR organization, the Compound Bank Project, Adaptive Screening, and more in this past presentation.
The Development and Management of the Compound Library Consortium (CLC) | 13th Compound and Sample Management Summit
Peter Guzzo, Director, Drug Discovery at Albany Molecular Research, Inc., and past speaker at our summit, explores improving efficiencies in Drug Discovery, the challenges facing existing small molecule chemical library collections, and the framework for the Compound Library Consortium in this thorough past presentation.
Researchers and engineers handling time and temperature-sensitive substances work together despite cultural boundaries and differing technological workflows, which is a process that requires expertise and agility. How does one achieve this? To answer this question we asked two past speakers to share their expertise on workflows, automation and outsourcing.
Compound and BioSample Management Market Trend Report 2017 | 13th Compound and Sample Management Summit
Sample to Screen: Process Improvements at Merck - Joseph E. Cowan and Edward M. Hudak | 13th Compound and Sample Management Summit
Past speakers Joseph E. Cowan and Edward M. Hudak discuss Discovery Sample Management: Enable drug discovery research through management of Merck’s chemical and biological assets, development of efficient materials management and process workflows, and innovative scientific engineering design.
Ensuring Data Quality in an Outsourcing Environment - Elizabeth Admirand | 13th Compound and Sample Management Summit
Past speaker Elizabeth Admirand, Principal Research Associate, Lead Discovery, shares insight into how Epizyme conducted detailed CRO site checks on a global scale.
Rapid Translational Research from Bench to Bedside and Back at St. Jude Children’s Research Hospital – Heather Long and Asa Karlström | 13th Compound and Sample Management Summit
Past speakers Heather Long and Asa Karlström provide expert insight on the background of compound management in the Department of Chemical Biology and Therapeutics including communication between collaborators, tracking and QC of compounds and synergy concept and formatting.
Exclusive Q&A: Ryan M. Winters, Manager - Biosample Repository Facility, Fox Chase Cancer Center | 13th Compound and Sample Management Summit
SPEAKER SPOTLIGHT: William Janzen, Executive Director, Lead Discovery, Epizyme | 13th Compound and Sample Management Summit
In lead up to the 13th Compound and Sample Management Summit, we sat down with William Janzen, Executive Director, Lead Discovery at Epizyme for industry insight into the challenges that both small and big pharma face, as well as key trends to look out for.
How to Fast-track Drug Development Productivity: The Role of Innovation in Life Sciences | 13th Compound and Sample Management Summit
Compound and Biosample Management IT issues, Troubleshooting Guide | 13th Compound and Sample Management Summit
The global lab automation market is projected to reach $5.052 million by 2020, with compound management standing as a segment of this market. Lab automation is seen as a key way to return both time and money to compound management departments. Therefore, having sufficient automation technologies to handle and preserve the quality of samples and provide timely access to samples are at the heart of compound management.